SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm |
mammary tumor number |
7,12-dimethyltetraphene (65 mg/kg) |
Stieber D, et al., Int J Cancer. 2007 Jan 17 |
mammary gland integrity trait |
female |
186 days-191 days |
46 |
7.61 |
null |
0.07 |
0.45 |
necropsy |
0 |
DMBA oral gavage |
0 |
necropsy |
|
11342 |
73 |
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm |
post-insult time to mammary tumor formation |
7,12-dimethyltetraphene (65 mg/kg) |
Stieber D, et al., Int J Cancer. 2007 Jan 17 |
mammary gland integrity trait |
female |
107 days-112 days |
14 |
53.4 |
d |
0.64 |
2.4 |
manual palpation method |
0 |
DMBA oral gavage |
0 |
|
|
11344 |
73 |
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm |
mammary tumor number |
7,12-dimethyltetraphene (65 mg/kg) |
Stieber D, et al., Int J Cancer. 2007 Jan 17 |
mammary gland integrity trait |
female |
186 days-191 days |
14 |
3.93 |
null |
0.17 |
0.64 |
necropsy |
0 |
DMBA oral gavage |
0 |
necropsy |
|
11341 |
73 |
SPRD/Ztm |
mammary tumor number |
7,12-dimethyltetraphene (65 mg/kg) |
Stieber D, et al., Int J Cancer. 2007 Jan 17 |
mammary gland integrity trait |
female |
186 days-191 days |
48 |
11.23 |
null |
0.07 |
0.51 |
necropsy |
0 |
DMBA oral gavage |
0 |
necropsy |
|
11340 |
73 |
SPRD/Ztm |
post-insult time to mammary tumor formation |
7,12-dimethyltetraphene (65 mg/kg) |
Stieber D, et al., Int J Cancer. 2007 Jan 17 |
mammary gland integrity trait |
female |
97 days-102 days |
48 |
43.8 |
d |
0.13 |
0.9 |
manual palpation method |
0 |
DMBA oral gavage |
0 |
|
|
11343 |
73 |
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm |
post-insult time to mammary tumor formation |
7,12-dimethyltetraphene (65 mg/kg) |
Stieber D, et al., Int J Cancer. 2007 Jan 17 |
mammary gland integrity trait |
female |
99 days-104 days |
46 |
45.91 |
d |
0.19 |
1.27 |
manual palpation method |
0 |
DMBA oral gavage |
0 |
|
|
11345 |
73 |
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm |
mammary tumor growth rate |
7,12-dimethyltetraphene (65 mg/kg) |
Stieber D, et al., Int J Cancer. 2007 Jan 17 |
mammary gland integrity trait |
female |
107 days-128 days |
14 |
0.62 |
cm/week |
0.02 |
0.08 |
unspecified method |
0.0 |
DMBA oral gavage |
0 |
|
the first 3 weeks of tumor growth |
11347 |
73 |
SPRD/Ztm |
mammary tumor growth rate |
7,12-dimethyltetraphene (65 mg/kg) |
Stieber D, et al., Int J Cancer. 2007 Jan 17 |
mammary gland integrity trait |
female |
97 days-118 days |
48 |
0.7 |
cm/week |
0.0 |
0.03 |
unspecified method |
0.0 |
DMBA oral gavage |
0 |
|
the first 3 weeks of tumor growth |
11346 |
73 |
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm |
mammary tumor growth rate |
7,12-dimethyltetraphene (65 mg/kg) |
Stieber D, et al., Int J Cancer. 2007 Jan 17 |
mammary gland integrity trait |
female |
99 days-120 days |
46 |
0.79 |
cm/week |
0.01 |
0.05 |
unspecified method |
0.0 |
DMBA oral gavage |
0 |
|
the first 3 weeks of tumor growth |
11348 |
73 |